A. J. Alberg, J. G. Ford, and J. M. Samet, Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines, Chest, vol.132, pp.29-55, 2007.

B. K. Edwards, M. L. Brown, and P. A. Wingo, Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment, J Natl Cancer Inst, vol.97, pp.1407-1434, 2005.

D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA Cancer J Clin, vol.55, pp.74-108, 2002.

P. Goldstraw, J. Crowley, and K. Chansky, The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, J Thorac Oncol, vol.2, pp.706-720, 2007.

C. F. Mountain and C. M. Dresler, Regional lymph node classification for lung cancer staging, Chest, vol.111, pp.1718-1741, 1997.

C. F. Mountain, Revisions in the International System for Staging Lung Cancer, Chest, vol.111, pp.1710-1717, 1997.

P. Broet, S. Camilleri-broet, and S. Zhang, Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection, Cancer Res, vol.69, pp.1055-62, 2009.

M. Reinecke and . Neurotensin, Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone, Prog Histochem Cytochem, vol.16, pp.1-172, 1985.

I. Baca, G. E. Feurle, A. Schwab, U. Mittmann, W. Knauf et al., Effect of neurotensin on exocrine pancreatic secretion in dogs, Digestion, vol.23, pp.174-83, 1982.

S. Andersson, S. Rosell, U. Hjelmquist, D. Chang, and K. Folkers, Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin, Acta Physiol Scand, vol.100, pp.231-236, 1977.

D. Zhao and C. Pothoulakis, Rho GTPases as therapeutic targets for the treatment of inflammatory diseases, Expert Opin Ther Targets, vol.7, pp.583-92, 2003.

J. Leyton, L. Garcia-marin, R. T. Jensen, and T. W. Moody, Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells, Eur J Pharmacol, vol.442, pp.179-86, 2002.

R. A. Ehlers, Y. Zhang, M. R. Hellmich, and B. M. Evers, Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2, Biochem Biophys Res Commun, vol.269, pp.704-712, 2000.

T. W. Moody, J. Chiles, M. Casibang, E. Moody, D. Chan et al., SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells, Peptides, vol.22, pp.109-124, 2001.

F. Souaze, V. Viardot-foucault, and N. Roullet, Neurotensin receptor 1 gene activation by the Tcf/?-catenin pathway is an early event in human colonic adenomas, Carcinogenesis, vol.27, pp.708-724, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-02459595

J. J. Maoret, Y. Anini, C. Rouyer-fessard, D. Gully, and M. Laburthe, Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice, Int J Cancer, vol.80, pp.448-54, 1999.

M. Toy-miou-leong, C. L. Cortes, A. Beaudet, W. Rostene, and P. Forgez, Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation, J Biol Chem, vol.279, pp.12636-12682, 2004.

M. Najimi, F. Souaze, and M. Mendez, Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor, J Biol Chem, vol.273, pp.21634-21675, 1998.

S. Somai, A. Gompel, W. Rostene, and P. Forgez, Neurotensin counteracts apoptosis in breast cancer cells, Biochem Biophys Res Commun, vol.295, pp.482-490, 2002.

F. Souaze, S. Dupouy, and V. Viardot-foucault, Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression, Cancer Res, vol.66, pp.6243-6252, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-02459047

S. Shimizu, J. Tsukada, and T. Sugimoto, Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway, Int J Cancer, vol.123, pp.1816-1839, 2008.

S. Dupouy, V. Viardot-foucault, and M. Alifano, The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression, PLoS ONE, vol.4, p.4223, 2009.

K. Kozaki, O. Miyaishi, and T. Tsukamoto, Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation, Cancer Res, vol.60, pp.2535-2575, 2000.

F. Souaze, W. Rostene, and P. Forgez, Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms, J Biol Chem, vol.272, pp.10087-94, 1997.
URL : https://hal.archives-ouvertes.fr/inserm-02459623

V. Scarceriaux, D. Pelaprat, P. Forgez, A. M. Lhiaubet, and W. Rostene, Effects of dexamethasone and forskolin on neurotensin production in rat hypothalamic cultures, Endocrinology, vol.136, pp.2554-60, 1995.

J. J. Maoret, D. Pospai, and C. Rouyer-fessard, Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments, Biochem Biophys Res Commun, vol.203, pp.465-71, 1994.

D. X. Nguyen, A. C. Chiang, and X. H. Zhang, WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis, Cell, vol.138, pp.51-62, 2009.

H. W. Koon, Y. S. Kim, and H. Xu, Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis, Proc Natl Acad Sci U S A, vol.106, pp.8766-71, 2009.

D. Zhao, Y. Zhan, H. Zeng, H. W. Koon, M. P. Moyer et al., Neurotensin stimulates interleukin-8 expression through modulation of I ? B ? phosphorylation and p65 transcriptional activity: involvement of protein kinase C ?, Mol Pharmacol, vol.67, pp.2025-2056, 2005.

H. A. Wakelee, J. H. Schiller, and D. R. Gandara, Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial, Clin Lung Cancer, vol.8, pp.18-21, 2006.

S. S. Hecht, Tobacco smoke carcinogens and lung cancer, J Natl Cancer Inst, vol.91, pp.1194-210, 1999.

J. Rubins, M. Unger, and G. L. Colice, Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidencebased clinical practice guideline, Chest, vol.132, pp.355-67, 2007.

Y. Lu, W. Lemon, and P. Y. Liu, A gene expression signature predicts survival of patients with stage I non-small cell lung cancer, PLoS Med, vol.3, pp.4401-4410, 2006.

, Clin Cancer Res Marco Alifano